Evidence map›Paper›PMID 39440702›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

The Alzheimer's Disease Neuroimaging Initiative-4 (ADNI-4) Engagement Core: A culturally informed, community-engaged research (CI-CER) model to advance brain health equity.

Mónica Rivera Mindt, Alyssa Arentoft, Amanda T Calcetas, Vanessa A Guzman, Hannatu Amaza, Adeyinka Ajayi, Miriam T Ashford, Omobolanle Ayo, Lisa L Barnes, Alicia Camuy and 22 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Predicting Preclinical Cognitive Decline Using Plasma P-tau217 andmedRxiv : the preprint server for health sciences · 2026
    Article
  8. Review
  9. Review
  10. Nuclear medicine and molecular imaging · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Mónica Rivera MindtDepartment of Psychology, Fordham University, Bronx, New York, USA.
Alyssa ArentoftDepartment of Psychology, California State University, Northridge, Northridge, California, USA.
Amanda T CalcetasDepartment of Psychology, Fordham University, Bronx, New York, USA.
Vanessa A GuzmanDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hannatu AmazaDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Adeyinka AjayiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Miriam T AshfordNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Omobolanle AyoDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lisa L BarnesDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Alicia CamuyDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Catherine ContiNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Adam DiazNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Bashir EasterCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
David J GonzalezCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Yolanda Graham DotsonCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Isabella HoangDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Kaori Kubo GermanoDepartment of Psychology, Fordham University, Bronx, New York, USA.
Gladys E MaestreCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Fabiola MagañaDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Oanh L MeyerCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Melanie J MillerNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Rachel NoshenyNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Van M Ta ParkCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Shaniya ParkinsDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lisa Renier ThomasDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Joe StrongDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Sandra TalaveraDepartment of Psychology, Fordham University, Bronx, New York, USA.
Steven P VerneyCommunity Science Partnership Board (CSPB), Alzheimer's Disease Neuroimaging Initiative, New York, New York, USA.
Trinity WeisenselDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Michael W WeinerNorthern California Institute for Research and Education (NCIRE), San Francisco, California, USA.
Ozioma C OkonkwoDepartment of Medicine, Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Alzheimer's Disease Neuroimaging Initiative

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI Laurel A Beckett · 2016 to 2026
$226.7M
Workforce Development CoreU54HG013247 · NHGRI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI SARAH A. WILLIAMS-BLANGERO · 2023 to 2026
$10.5M
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for ProgressP30AG059305 · NIA · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI Gladys E. Maestre · 2018 to 2026
$5.8M
Expanding the CAARN to accelerate research on multiple chronic conditions with rural and African-American communities and health-care providersR33AG061699 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Dorothy Farrar Edwards, Hongrui Jiang · 2019 to 2026
$5.1M
Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approachesU01AG068221 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DESTEFANO, ANITA L, LIN, HONGHUANG · 2021 to 2024
$2.5M
NHGRI NIH HHS U54 HG013247NIA NIH HHS P30 AG059305NIA NIH HHS R33 AG061699NIA NIH HHS U01 AG068221NIA NIH HHS U19 AG024904NIA NIH HHS U19AG024904
6 · The paper itself

Abstract

introductionThe Alzheimer's Disease Neuroimaging Initiative-4 (ADNI-4) Engagement Core was launched to advance Alzheimer's disease (AD) and AD-related dementia (ADRD) health equity research in underrepresented populations (URPs). We describe our evidence-based, scalable culturally informed, community-engaged research (CI-CER) model and demonstrate its preliminary success in increasing URP enrollment.

methodsURPs include ethnoculturally minoritized, lower education (≤ 12 years), and rural populations. The CI-CER model includes: (1) culturally informed methodology (e.g., less restrictive inclusion/exclusion criteria, sociocultural measures, financial compensation, results disclosure, Spanish Language Capacity Workgroup) and (2) inclusive engagement methods (e.g., the Engagement Core team; Hub Sites; Community-Science Partnership Board).

resultsAs of April 2024, 60% of ADNI-4 new in-clinic enrollees were from ethnoculturally or educationally URPs. This exceeds ADNI-4's ≥ 50% URP representation goal for new enrollees but may not represent final enrollment. DISCUSSION: Findings show a CI-CER model increases URP enrollment in AD/ADRD clinical research and has important implications for clinical trials to advance health equity. HIGHLIGHTS: The Alzheimer's Disease Neuroimaging Initiative-4 (ADNI-4) uses a culturally informed, community-engaged research (CI-CER) approach. The CI-CER approach is scalable and sustainable for broad, multisite implementation. ADNI-4 is currently exceeding its inclusion goals for underrepresented populations.

Indexed as

Alzheimer DiseaseHealth EquityNeuroimagingAgedBrainCommunity-Based Participatory ResearchFemaleHumansMaleAlzheimer's diseasecognitive agingcommunity‐engaged researchcultural humilitydementiadiversityexternal validitygeneralizabilityhealth disparitieshealth equityinclusion scienceinclusive participationunderrepresented populations

Identifiers

PMID39440702
PMCPMC11667532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.